marketcap
Horizon Therapeutics Public Limited Company HZNP
$ 116.3
0.0%
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q2
added 08-08-2023
Horizon Therapeutics Public Limited Company Financial Ratios 2011-2024 | HZNP
Annual Financial Ratios Horizon Therapeutics Public Limited Company
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
48.4 | 45.5 | 38.3 | 12.5 | -90.8 | -7.0 | -15.1 | 69.0 | -5.2 | -4229.5 | -969.6 | -311.2 |
P/S |
6.9 | 7.5 | 6.8 | 5.5 | 2.9 | 2.3 | 2.5 | 3.6 | 4.6 | 6118.9 | 3704.8 | 5079.8 |
EPS |
2.3 | 2.4 | 1.9 | 3.1 | -0.2 | -2.1 | -1.0 | 0.3 | -3.1 | -2.3 | -2.3 | -12.6 |
EV (Enterprise Value) |
22.9 B | 22.7 B | 12.8 B | 8.36 B | 5.28 B | 4.91 B | 5.01 B | 3.61 B | 1.73 B | 630 B | 85.1 B | 35.3 B |
EBITDA per Share |
4.4 | 3.98 | 3.77 | 1.49 | 1.89 | -0.351 | 0.471 | 0.247 | 0.218 | -0.000256 | -0.00189 | -0.0129 |
EV/EBITDA |
25.1 | 18.1 | 24.5 | 14.1 | -63.1 | 50.1 | 78.1 | 82.1 | -38667.6 | -1160.1 | -303.3 | |
PEG |
-0.49 | -0.34 | -0.32 | -0.01 | 1.02 | -0.06 | 0.03 | -0.64 | -0.0 | -1194.83 | 11.82 | 3.11 |
P/B |
2.8 | 2.8 | 2.5 | 3.3 | 3.3 | 2.5 | 2.0 | 2.1 | 2.5 | -12840.0 | 803.3 | 767.7 |
P/CF |
20.1 | 23.5 | 26.8 | 17.6 | 18.4 | 8.8 | 7.1 | 14.6 | 57.2 | -6963.7 | -1092.8 | -817.8 |
ROE % |
10.28 | 11.44 | 9.68 | 26.22 | -3.64 | -35.33 | -13.10 | 3.01 | -48.80 | 303.58 | -82.84 | -246.70 |
ROA % |
5.72 | 6.16 | 6.42 | 12.92 | -0.97 | -8.33 | -3.86 | 1.29 | -23.66 | -58.99 | -45.25 | -112.03 |
ROCE % |
7.56 | 6.97 | 9.43 | 1.83 | 1.17 | -9.99 | -3.96 | -3.70 | -1.75 | -20.47 | -50.21 | -156.47 |
Current Ratio |
- | - | - | 2.3 | 2.2 | 1.6 | 1.7 | 3.1 | 1.5 | 2.6 | 3.2 | 1.0 |
DSO |
65.8 | 73.1 | 88.6 | 114.7 | 140.5 | 140.0 | 113.7 | 101.5 | 90.9 | 56.7 | 55.6 | 126.2 |
DIO |
78.4 | 69.1 | 44.2 | 54.2 | 51.6 | 54.1 | 172.2 | 38.4 | 96.8 | 249.6 | 149.9 | 60.3 |
DPO |
36.9 | 15.6 | 20.3 | 21.7 | 28.2 | 25.7 | 48.9 | 27.6 | 97.4 | 247.1 | 172.9 | 411.9 |
Operating Cycle |
144.2 | 142.2 | 132.8 | 169.0 | 192.0 | 194.1 | 286.0 | 139.8 | 187.6 | 306.3 | 205.5 | 186.5 |
Cash Conversion Cycle |
107.4 | 126.7 | 112.5 | 147.3 | 163.8 | 168.4 | 237.1 | 112.2 | 90.2 | 59.2 | 32.5 | -225.3 |
All numbers in USD currency
Quarterly Financial Ratios Horizon Therapeutics Public Limited Company
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.56 | 0.24 | - | 0.59 | 0.27 | 0.89 | - | 1.44 | 0.7 | -0.55 | 0.86 | 1.38 | -0.42 | -0.07 | 3.16 | 0.1 | -0.03 | -0.19 | 0.6 | 0.2 | -0.15 | -0.9 | -0.23 | -0.39 | -1.28 | -0.56 | -0.81 | -0.04 | 0.09 | -0.28 | 0.15 | 0.02 | 0.21 | -0.16 | -0.27 | 0.03 | -0.38 | -3.07 | - | -0.08 | -0.29 | -0.36 | - | -0.47 | -0.68 | -0.98 | - | -1.3 | -7.78 | - |
EBITDA per Share |
0.65 | 0.57 | - | 1.96 | 0.41 | 1.26 | - | 2.6 | 0.63 | -0.4 | 1.08 | 2.07 | 0.92 | 0.26 | 0.29 | 1.21 | 0.77 | 0.33 | 0.49 | 1.49 | 0.82 | -0.33 | -0.41 | 1.15 | -0.26 | -0.21 | -0.81 | 0.83 | 0.84 | 0.15 | 0.24 | 0.88 | 0.12 | 0.18 | 0.07 | 0.07 | 0.05 | 0.1 | -0.09 | 0.05 | -0.19 | -0.27 | -0.36 | -0.42 | -0.48 | -0.78 | -4.55 | -0.95 | -4.48 | -0.3 |
ROE % |
8.86 | 7.70 | 8.17 | 15.51 | 20.15 | 22.80 | 8.02 | 12.75 | 12.69 | 6.82 | 9.68 | 32.07 | 25.63 | 27.39 | 26.22 | 7.64 | 9.61 | 7.76 | -3.22 | -15.24 | -24.47 | -43.51 | -40.13 | -46.60 | -40.63 | -18.33 | -12.81 | -1.04 | -0.33 | 0.91 | 3.01 | -4.68 | -4.54 | -12.11 | -48.80 | 166.71 | 177.52 | 220.23 | 303.58 | 70.97 | 43.79 | -15.28 | -82.84 | -227.00 | -248.53 | -252.38 | -246.70 | -37.53 | -25.35 | -16.71 |
ROA % |
4.98 | 5.95 | 6.18 | 9.97 | 9.92 | 11.85 | 4.15 | 7.29 | 8.31 | 5.07 | 6.42 | 16.64 | 12.23 | 13.43 | 12.92 | 2.13 | 2.57 | 2.06 | -0.97 | -4.46 | -6.82 | -11.18 | -9.55 | -11.68 | -10.31 | -4.98 | -3.89 | -0.06 | 0.18 | 0.87 | 1.29 | -2.33 | -2.26 | -5.74 | -23.28 | -61.18 | -63.54 | -68.39 | -58.99 | -30.80 | -37.36 | -41.80 | -45.26 | -108.62 | -116.93 | -116.70 | -112.06 | -17.05 | -11.51 | -7.59 |
ROCE % |
6.08 | 6.17 | 6.21 | 10.49 | 12.80 | 12.89 | 3.90 | 8.52 | 8.64 | 7.48 | 9.43 | 6.28 | 3.19 | 3.14 | 3.41 | 4.49 | 5.10 | 4.75 | 1.17 | -3.30 | -5.97 | -11.74 | -11.19 | -12.75 | -12.58 | -6.29 | -3.95 | 0.95 | 3.22 | 1.14 | 2.05 | 1.64 | -1.36 | -0.90 | -0.91 | -4.66 | -4.67 | -11.44 | -20.48 | -31.75 | -42.35 | -46.48 | -50.22 | -151.96 | -174.14 | -181.51 | -184.14 | -34.10 | -19.05 | -15.22 |
Current Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.3 | 2.1 | 2.2 | 1.8 | 1.6 | 1.8 | 1.8 |
DSO |
64.8 | 71.3 | - | 31.9 | 35.6 | 67.9 | - | 66.5 | 64.6 | 147.0 | 80.8 | 94.6 | 130.1 | 137.0 | 102.6 | 111.2 | 116.3 | 142.1 | 119.3 | 130.4 | 140.0 | 177.3 | 134.8 | 136.1 | 127.7 | 146.9 | 89.9 | 133.7 | 108.4 | 115.0 | 78.5 | 84.8 | 111.1 | 114.7 | 65.0 | 89.8 | 102.1 | 79.0 | 48.4 | 60.4 | 130.8 | 101.9 | 49.7 | 50.0 | 82.3 | 105.5 | 61.4 | 792.8 | 162.1 | - |
DIO |
69.5 | 73.1 | - | 37.1 | 44.9 | 95.9 | - | 90.0 | 112.8 | 142.6 | - | 45.4 | 56.5 | 60.5 | - | 54.6 | 55.1 | 54.1 | 47.0 | 50.9 | 50.7 | 46.5 | 39.3 | 44.9 | 43.3 | 77.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
33.6 | 50.8 | - | 6.3 | 13.3 | 20.6 | - | 18.6 | 21.6 | 36.7 | - | 22.7 | 28.3 | 27.7 | - | 21.8 | 22.0 | 26.8 | 28.0 | 30.3 | 30.3 | 26.9 | 22.1 | 25.3 | 24.4 | 28.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
134.2 | 144.4 | - | 69.0 | 80.5 | 163.8 | - | 156.4 | 177.4 | 289.5 | 80.8 | 139.9 | 186.6 | 197.4 | 102.6 | 165.8 | 171.4 | 196.2 | 166.2 | 181.2 | 190.7 | 223.8 | 174.1 | 181.0 | 171.0 | 224.5 | 89.9 | 133.7 | 108.4 | 115.0 | 78.5 | 84.8 | 111.1 | 114.7 | 65.0 | 89.8 | 102.1 | 79.0 | 48.4 | 60.4 | 130.8 | 101.9 | 49.7 | 50.0 | 82.3 | 105.5 | 61.4 | 792.8 | 162.1 | - |
Cash Conversion Cycle |
100.6 | 93.6 | - | 62.7 | 67.2 | 143.2 | - | 137.8 | 155.8 | 252.8 | 80.8 | 117.2 | 158.3 | 169.7 | 102.6 | 143.9 | 149.3 | 169.4 | 138.2 | 150.9 | 160.5 | 196.9 | 152.0 | 155.8 | 146.7 | 195.9 | 89.9 | 133.7 | 108.4 | 115.0 | 78.5 | 84.8 | 111.1 | 114.7 | 65.0 | 89.8 | 102.1 | 79.0 | 48.4 | 60.4 | 130.8 | 101.9 | 49.7 | 50.0 | 82.3 | 105.5 | 61.4 | 792.8 | 162.1 | - |
All numbers in USD currency